Patents by Inventor Rachel Cohen

Rachel Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220098598
    Abstract: Genetically modified cells with at least one codon substituted to a synonymous codon, and with modified replicative fitness as compared to the unmodified cell, wherein a slower translating synonymous codon increases replicative fitness and a faster translating codon decreased replicative fitness are provided. Further, vaccine composition comprising those cells as well as methods for modifying replicative fitness of a cell are provided.
    Type: Application
    Filed: December 16, 2021
    Publication date: March 31, 2022
    Inventors: Tamir TULLER, Hadas ZUR, Rachel COHEN-KUPIEC
  • Patent number: 11236344
    Abstract: Genetically modified cells with at least one codon substituted to a synonymous codon, and with modified replicative fitness as compared to the unmodified cell, wherein a slower translating synonymous codon increases replicative fitness and a faster translating codon decreased replicative fitness are provided. Further, vaccine composition comprising those cells as well as methods for modifying replicative fitness of a cell are provided.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: February 1, 2022
    Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Tamir Tuller, Hadas Zur, Rachel Cohen-Kupiec
  • Patent number: 11119764
    Abstract: A method and system for improving document lifecycle editing and storage technology is provided. The method includes enabling interactions between a user and a hardware controller. Editor profiles associated with editing privileges of the user are generated. The editor profiles include parameters generated based on a performance of past edits. The editing tasks are automated task difficulty attributes associated with a difficulty of executing the editing tasks are generated. The editing tasks may include readability and consolidation tasks. An optimized version of the editing tasks is assigned to software editors and time periods associated with the software editors completing the editing tasks are tracked. The optimized version of the editing tasks is generated based on the editor profiles and new tasks for assignment. User permissions and alerts are monitored and recommendation actions associated with the editing tasks are generated. The editing tasks are modified for future execution.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: September 14, 2021
    Assignee: International Business Machines Corporation
    Inventors: Jason Boada, Jeremy Chase, Qin Shirley Held, Rachel Cohen, Munish Goyal
  • Patent number: 11100290
    Abstract: A method and system for improving linguistic data and storage technology is provided. The method includes receiving data input text from a user and identifying text within the data input text. The data input text is edited and improvements in the data input text are detected via a machine learning process. In response, a modified version of the user interface is generated for allowing additional users to view and modify additional data input text. Change attributes associated with the data input text with respect to the modified version of the user interface are determined and alternative input suggestions are ranked. Editing data and code are generated in response to an editor engine interacting with a hardware controller. The editing data and code is executed thereby updating and modifying functions associated with software engines to increase an efficiency of future recommendations associated with future data input text analysis.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: August 24, 2021
    Assignee: International Business Machines Corporation
    Inventors: Jason Boada, Qin Shirley Held, Rachel Cohen, Munish Goyal, Dangaia Sims
  • Publication number: 20200379755
    Abstract: A method and system for improving document lifecycle editing and storage technology is provided. The method includes enabling interactions between a user and a hardware controller. Editor profiles associated with editing privileges of the user are generated. The editor profiles include parameters generated based on a performance of past edits. The editing tasks are automated task difficulty attributes associated with a difficulty of executing the editing tasks are generated. The editing tasks may include readability and consolidation tasks. An optimized version of the editing tasks is assigned to software editors and time periods associated with the software editors completing the editing tasks are tracked. The optimized version of the editing tasks is generated based on the editor profiles and new tasks for assignment. User permissions and alerts are monitored and recommendation actions associated with the editing tasks are generated. The editing tasks are modified for future execution.
    Type: Application
    Filed: May 30, 2019
    Publication date: December 3, 2020
    Inventors: Jason Boada, Jeremy Chase, Qin Shirley Held, Rachel Cohen, Munish Goyal
  • Publication number: 20200380075
    Abstract: A method and system for improving linguistic data and storage technology is provided. The method includes receiving data input text from a user and identifying text within the data input text. The data input text is edited and improvements in the data input text are detected via a machine learning process. In response, a modified version of the user interface is generated for allowing additional users to view and modify additional data input text. Change attributes associated with the data input text with respect to the modified version of the user interface are determined and alternative input suggestions are ranked. Editing data and code are generated in response to an editor engine interacting with a hardware controller. The editing data and code is executed thereby updating and modifying functions associated with software engines to increase an efficiency of future recommendations associated with future data input text analysis.
    Type: Application
    Filed: May 30, 2019
    Publication date: December 3, 2020
    Inventors: Jason Boada, Qin Shirley Held, Rachel Cohen, Munish Goyal, Dangaia Sims
  • Patent number: 10496148
    Abstract: Technologies for managing power consumption include a power management device that determines a context associated with a user of computing devices located within a building and in communication with the power management device. The power management device compares the context associated with the user to a power management policy. The power management policy includes power management rules that define power consumption levels for the computing devices based on the context associated with the user. The power management device communicates with the computing devices to adjust the power consumption levels in response to the context associated with the user satisfying a power management rule.
    Type: Grant
    Filed: December 24, 2013
    Date of Patent: December 3, 2019
    Assignee: Intel Corporation
    Inventors: Tomer Rider, Rachel Cohen
  • Publication number: 20180334679
    Abstract: Genetically modified cells with at least one codon substituted to a synonymous codon, and with modified replicative fitness as compared to the unmodified cell, wherein a slower translating synonymous codon increases replicative fitness and a faster translating codon decreased replicative fitness are provided. Further, vaccine composition comprising those cells as well as methods for modifying replicative fitness of a cell are provided.
    Type: Application
    Filed: May 21, 2018
    Publication date: November 22, 2018
    Inventors: Tamir Tuller, Hadas Zur, Rachel Cohen-Kupiec
  • Publication number: 20160291671
    Abstract: Technologies for managing power consumption include a power management device that determines a context associated with a user of computing devices located within a building and in communication with the power management device. The power management device compares the context associated with the user to a power management policy. The power management policy includes power management rules that define power consumption levels for the computing devices based on the context associated with the user. The power management device communicates with the computing devices to adjust the power consumption levels in response to the context associated with the user satisfying a power management rule.
    Type: Application
    Filed: December 24, 2013
    Publication date: October 6, 2016
    Inventors: Tomer RIDER, Rachel COHEN
  • Patent number: 9346746
    Abstract: The subject invention provides R(+)-N-formyl-propargyl-aminoindan and a composition containing N-propargyl-1(R)-aminoindan or a pharmaceutically acceptable salt thereof, and a compound of R(+)-N-formyl-propargyl-aminoindan.
    Type: Grant
    Filed: October 9, 2012
    Date of Patent: May 24, 2016
    Assignee: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Muhammad Safadi, Anton Frenkel, Michal Keisar, Danit Licht, Eliezer Bahar, Ramy Lidor-Hadas, Marina Zholkovsky, Rachel Cohen
  • Patent number: 9339469
    Abstract: The subject invention provides R(+)-N-methyl-propargyl-aminoindan or a pharmaceutically acceptable salt thereof and a composition containing R(+)-N-propargyl-1(R)-aminoindan or a pharmaceutically acceptable salt thereof, and a compound of R(+)-N-methyl-propargyl-aminoindan or a salt thereof.
    Type: Grant
    Filed: October 9, 2012
    Date of Patent: May 17, 2016
    Assignee: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Muhammad Safadi, Anton Frenkel, Michal Keisar, Danit Licht, Eliezer Bahar, Ramy Lidor-Hadas, Marina Zholkovsky, Rachel Cohen
  • Publication number: 20140186514
    Abstract: Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.
    Type: Application
    Filed: December 23, 2013
    Publication date: July 3, 2014
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Muhammad Safadi, Daniella Licht, Rachel Cohen, Anton Frenkel, Marina Zholkovsky
  • Publication number: 20120263789
    Abstract: Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.
    Type: Application
    Filed: June 29, 2012
    Publication date: October 18, 2012
    Inventors: Muhammad Safadi, Daniella Licht, Rachel Cohen, Anton Frenkel, Marina Zholkovsky
  • Patent number: 8221750
    Abstract: Anti-A?P scFvs and single domain antibodies were generated, and when these antibodies were displayed on filamentous phage or as soluble protein molecules, stabilized by the maltose binding protein, they could prevent the fibrilization of A?p 1-40 and disaggregate A?p 1-40 fibrils generated in vitro. The anti-A?p scFv antibodies also stained amyloid neuritic plaques on slices from transgenic mice. The anti-A?P scFv and single domain antibodies can be used for inhibiting or treating Alzheimer's disease.
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: July 17, 2012
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Beka Solomon, Rachel Cohen-Kupiec
  • Publication number: 20120114650
    Abstract: Anti-A?P scFvs and single domain antibodies were generated, and when these antibodies were displayed on filamentous phage or as soluble protein molecules, stabilized by the maltose binding protein, they could prevent the fibrilization of A?p 1-40 and disaggregate A?p 1-40 fibrils generated in vitro. The anti-A?p scFv antibodies also stained amyloid neuritic plaques on slices from transgenic mice. The anti-A?P scFv and single domain antibodies can be used for inhibiting or treating Alzheimer's disease.
    Type: Application
    Filed: January 19, 2012
    Publication date: May 10, 2012
    Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Beka SOLOMON, Rachel Cohen-Kupiec
  • Publication number: 20120100189
    Abstract: Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.
    Type: Application
    Filed: December 23, 2011
    Publication date: April 26, 2012
    Inventors: Muhammad Safadi, Daniella Licht, Rachel Cohen, Anton Frenkel, Marina Zholkovsky
  • Patent number: 8124076
    Abstract: Anti-A?P scFvs and single domain antibodies were generated, and when these antibodies were displayed on filamentous phage or as soluble protein molecules, stabilized by the maltose binding protein, they could prevent the fibrilization of Abp 1-40 and disaggregate Abp 1-40 fibrils generated in vitro. The anti-A?p scFv antibodies also stained amyloid neuritic plaques on slices from transgenic mice. The anti-A?P scFv and single domain antibodies can be used for inhibiting or treating Alzheimer's disease.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: February 28, 2012
    Assignee: Ramot At Tel Aviv University Ltd.
    Inventors: Beka Solomon, Rachel Cohen-Kupiec
  • Publication number: 20120003310
    Abstract: Disclosed are formulations of rasagiline base which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. Also, disclosed are rasagiline citrate salt and the use and process of manufacture thereof.
    Type: Application
    Filed: January 21, 2010
    Publication date: January 5, 2012
    Inventors: Muhammad Safadi, Daniella Licht, Rachel Cohen, Anton Frenkel, Tamas Koltai, Marina Zholkovsky
  • Patent number: 8080584
    Abstract: Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.
    Type: Grant
    Filed: June 9, 2009
    Date of Patent: December 20, 2011
    Assignee: Teva Pharmaceuticals Industries, Ltd.
    Inventors: Muhammad Safadi, Daniella Licht, Rachel Cohen, Anton Frenkel, Marina Zholkovsky
  • Publication number: 20100189787
    Abstract: Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.
    Type: Application
    Filed: June 9, 2009
    Publication date: July 29, 2010
    Inventors: Muhammad Safadi, Daniella Licht, Rachel Cohen, Anton Frenkel, Marina Zholkovsky